PAD - Prescribing Advisory Database
Surrey
Prescribing Advisory Database

Guidelines : Hypertension

Detail

Condition :
Hypertension
Keywords :
ACE, ARB
BNF Codes :

Committee Recommendations

Date
Committee Name
Narrative
Traffic Light Status
07 September 2022
Surrey Heartlands Integrated Care System Area Prescribing Committee (APC)

The Surrey Heartlands Integrated Care System Area Prescribing Committee (APC) has agreed the 1st line use of Angiotensin Receptor Blockers (ARBs) instead of an Angiotensin Converting Enzyme (ACE) inhibitor, for adults with hypertension where the use of an ARB or ACE is deemed equally appropriate.

Losartan or candesartan - 1st line

Alternative options:
Irebsartan - Green
Telmisartan - Green
Valsartan - Green
Olmesartan - Green

Azlisartan - do not initiate in new patients
Eprosartan - do not initiate in new patients

Local hypertension guidelines / pathways will be reviewed and updated in light of this decision

 
Green
06 July 2022
Surrey Heartlands Integrated Care System Area Prescribing Committee (APC)

The CVD medicines group are reviewing the Hypertension guidance on the Surrey PAD and recommend the adoption of the current NICE Hypertension guideline NG136 whilst the review process is underway.

 
N/A

Documents

Type
Document
Review Date
Evidence Review
Webpage

Supplementary documents (CCG specific documents)

No records returned.

Drugs

Below are listed drugs that are used to treat Hypertension.